Russian Journal of AllergyRussian Journal of Allergy1810-88302686-682XFarmarus Print Media147710.36691/RJA1477Review ArticleVaccination against COVID-19 for patients with primary immunodeficiency and hereditary angioedema: the position paper of the Russian Association of Allergology, Clinical Immunology, and the National Association of Experts in Primary ImmunodeficienciesIlyinaNatalya I.<p>MD, Dr. Sci. (Med.), Professor</p>instimmun@yandex.ruhttps://orcid.org/0000-0002-3556-969XKondratenkoIrina V.<p>MD, Dr. Sci. (Med.), Professor</p>ikondratenko@rambler.ruhttps://orcid.org/0000-0003-4834-4075LatyshevaElena A.<p>MD, Dr. Sci. (Med.)</p>ealat@mail.ruhttps://orcid.org/0000-0002-1606-205XLatyshevaTatiana V.<p>MD, Dr. Sci. (Med.), Professor</p>tvlat@mail.ruhttps://orcid.org/0000-0003-1508-0640MantoIrina A.<p>MD</p>irina.manto@yandex.ruhttps://orcid.org/0000-0001-6432-394XNazarovaEvgeniya V.<p>MD, Cand. Sci. (Med.)</p>ev.nazarova@nrcii.ruhttps://orcid.org/0000-0003-0380-6205FominaDaria S.<p>MD, Cand. Sci. (Med.)</p>daria.s.fomina@gmail.comhttps://orcid.org/0000-0002-5083-6637KhaitovMusa R.<p>MD, Dr. Sci. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences</p>mr.khaitov@nrcii.ruhttps://orcid.org/0000-0003-4961-9640ShcherbinaAnna Yu.<p>MD, Dr. Sci. (Med.), Professor Member of the Russian Academy of Sciences</p>shcher26@hotmail.comhttps://orcid.org/0000-0002-3113-4939National Research Center — Institute of Immunology Federal Medical-Biological Agency of RussiaRussian Children’s Clinical HospitalPirogov Russian National Research Medical UniversityMoscow State University of Medicine and Dentistry named after A.I. EvdokimovСlinical State Hospital № 52The First Sechenov Moscow State Medical University (Sechenov University)Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology06102021183981040109202102092021Copyright © 2021, Pharmarus Print Media2021<p>Since the end of 2019, the whole world has been suffering from the Corona virus-19 (COVID-19) pandemic due to the potentially severe acute respiratory infection caused by the SARS-CoV-2 virus. To date, the infection has led to more than 4 million deaths worldwide, and 140 thousand deaths in Russia. Vaccination against COVID-19 plays a key role in stopping the pandemic. According to the existing experience in infection prevention, mass vaccination will reduce the viruss expansion and the risk of vaccine-resistant strains developing. In the context of COVID-19, the question of the feasibility and safety of vaccination for patients with primary immunodeficiency and hereditary angioedema arises. The Russian Association of Allergists, Clinical Immunologists, and the National Association of Experts in Primary Immunodeficiencies have developed and approved a position paper on the vaccination for patients with primary immunodeficiency and hereditary angioedema against COVID-19.</p>
<p>This position paper provides answers to key questions regarding vaccination for patients with these diseases.</p>COVID-19vaccinationcoronavirusprimary immunodeficiencyPIDangioedemahereditary angioedemaHAEclinical guidelinesCOVID-19вакцинациякоронавируспервичный иммунодефицитПИДангиоотёкнаследственный ангиоотёкНАОклинические рекомендации[Bousfiha A, Jeddane L, Picard C, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66–81. doi: 10.1007/s10875-020-00758-x][Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40(1):24–64. doi: 10.1007/s10875-019-00737-x][World Health Organisation. Coronavirus [Internet]. Available from: https://www.who.int/health-topics/coronavirus. Accessed: Aug 28, 2021.][Wikipedia. Template: COVID-19 pandemic data [Internet]. Available from: https://en.wikipedia.org/wiki/Template:COVID-19_pandemic_data. Accessed: Aug 28, 2021.][World Health Organisation. Coronavirus disease (COVID-19): vaccines [Internet]. Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines. Accessed: Aug 28, 2021.][Goudouris ES, Pinto-Mariz F, Mendonça LO, et al. Outcome of SARS-CoV-2 Infection in 121 patients with inborn errors of immunity: a cross-sectional study. J Clin Immunol. 2021;1–11. doi: 10.1007/s10875-021-01066-8][Goldacker S, Draeger R, Warnatz K, et al. Active vaccination in patients with common variable immunodeficiency (CVID). Clin Immunol. 2007;124(3):294–303. doi: 10.1016/j.clim.2007.04.011][Pedersen G, Halstensen A, Sjursen H, et al. Pandemic № CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports. Scand J Immunol. 2011;74(2):210–218. doi: 10.1111/j.1365-3083.2011.02561.x][Rezaei N, Siadat SD, Aghamohammadi A, et al. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency. Clin Vaccine Immunol. 2010;17(4):524–528. doi: 10.1128/CVI.00389-09][Hanitsch LG, Löbel M, Mieves JF, et al. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency. Vaccine. 2016;34(21):2417–2423. doi: 10.1016/j.vaccine.2016.03.091][Paroli M, Accapezzato D, Francavilla V, et al. Long-lasting memory-resting and memory-effector CD4+T cells in human X-linked agammaglobulinemia. Blood. 2002;99(6):2131–2137. doi: 10.1182/blood.V99.6.2131][IPOPI. Vaccination against SARS-COV-2 (COVID-19) for patients with PID [Internet]. Available from: https://ipopi.org/latest-news-on-covid-19-and-pid-1/. Accessed: Aug 28, 2021.][Marciano BE, Huang CY, Joshi G, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–1141. doi: 10.1016/j.jaci.2014.02.028][Shearer WT, Fleisher TA, Buckley RH, et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol. 2014;133(4):961–966. doi: 10.1016/j.jaci.2013.11.043][Shaghaghi M, Shahmahmoodi S, Abolhassani H, et al. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995–2014. Emerg Infect Dis. 2016;22(10):1712–1719. doi: 10.3201/eid2210.151071][The State Register of Medicines. Registration certificate. Instructions for the KoviVak vaccine (inactivated whole-virion concentrated purified coronavirus vaccine) [Internet]. (In Russ). Available from: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=2b6c0483-705d-4b51-a722-2b954a9f918d&t=. Accessed: Aug 28, 2021.][The State Register of Medicines. Registration certificate. Instructions for the Gam-COVID-Vac vaccine (Combined vector vaccine for the prevention of coronavirus infection caused by the SARS-CoV-2 virus) [Internet]. (In Russ). Available from: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=7d85c1ea-a7f8-43e5-8975-a4827ee5d88a&t=. Accessed: Aug 28, 2021.][The State Register of Medicines. Registration certificate. Instructions for the EpiVacCorona vaccine (A vaccine based on peptide antigens for the prevention of COVID-19 [Internet]. (In Russ). Available from: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=35c6fdb8-821b-4f69-b566-f6245ad1f437&t=. Accessed: Aug 28, 2021.][The State Register of Medicines. Registration certificate. Instructions for the drug Sputnik Light (Vector vaccine for the prevention of coronavirus infection caused by the SARS-CoV-2 virus [Internet]. (In Russ). Available from: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=bd9750c9-178d-47cb-81e0-5e532219eebb&t=. Accessed: Aug 28, 2021.][Eibl MM, Wolf HM. Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities. Immunotherapy. 2015;7(12):1273–1292. doi: 10.2217/IMT.15.74][Hagin D, Freund T, Navon M, et al. Immunogenicity of pfizer-biontech COVID-19 vaccine in patients with inborn errors of immunity. J Allergy Clin Immunol. 2021;148(3):739–749. doi: 10.1016/j.jaci.2021.05.029][Ameratunga R, Longhurst H, Steele R, et al. Common variable immunodeficiency disorders, T cell responses to SARS-CoV-2 vaccines and the risk of Chronic COVID-19. J Allergy Clin Immunol Pract. 2021;S2213-2198(21):00702–00709. doi: 10.1016/j.jaip.2021.06.019][Temporary methodological recommendations. The procedure for vaccination of the adult population against COVID-19. Moscow; 2021. 50 p. (In Russ).][Latysheva TV, Latysheva EA, Manto IA, Kostinova AM. Vaccination of patients with primary immunodeficiency: a modern view of the problem. Russian Journal of Allergy. 2017;14(3):19–26. (In Russ).][Bliznec EA, Viktorova EA, Vishneva EA, et al. Hereditary angioedema. Clinical recommendations. Russian Journal of Allergy. 2021;18(2):77–114. (In Russ). doi: 10.36691/RJA1447]